Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shamrock Group is an India-based pharmaceutical manufacturing and export group focused on active pharmaceutical ingredients, intermediates, fine chemicals, veterinary products, and selected finished dosage forms. The group operates through Shamrock Pharmachemi and related entities and markets itself as a contract manufacturing, outsourcing, and regulatory-support partner for global pharmaceutical customers. Its capabilities include API development and production, carbapenem manufacturing from chemical intermediates through sterile vials, technical documentation, and support for regulated markets with DMFs and CEPs. Shamrock also highlights R&D laboratories, a pilot plant for CRAMS activities, and a broad export footprint across multiple countries. The business appears to be a commercially operating specialty manufacturer and supplier rather than a drug discovery biotech with a novel therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shamrock Group.